NCT00924586

Study of ONO-1101 in Patients Scheduled for Multi-Slice Computed Tomography (CT)

Study of ONO-1101 in Patients Scheduled for Multi-Slice Computed Tomography (CT), a Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Multi-Center Study

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 258 (actual)
• Sponsor: Ono Pharmaceutical Co., Ltd. · Industry
• Sex: All
• Age: 20 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate the efficacy and safety of ONO-1101 in patients scheduled for multi-slice CT, in a double-blind, randomized, placebo-controlled, parallel group, multi-center study.

Conditions

• Coronary Artery Disease

Interventions

Type	Name	Description
DRUG	ONO-1101	Placebo for one minute IV
DRUG	ONO-1101	0.125 mg/kg for one minute IV

Timeline

• Start date: 2009-06-01
• Primary completion: 2010-02-01
• First posted: 2009-06-19
• Last updated: 2012-06-13

Locations

2 sites across 1 country: Japan